Schaeffer's Top Stock Picks for '25

Biogen Stock Surges on Alzheimer's Treatment FDA Application

BIIB call traders are coming out of the woodwork today

Deputy Editor
Jul 8, 2020 at 9:57 AM
facebook X logo linkedin


Biopharmaceutical concern Biogen Inc (NASDAQ:BIIB) is up 7.8% to trade at $289.18 this morning, after the company submitted a marketing application to the Food and Drug Administration (FDA) regarding its Alzheimer's disease treatment aducanumab. According to a release from Biogen, "If approved, aducanumab would be the first treatment with the potential to meaningfully change the course of Alzheimer's disease."  

On the charts in the last 12 months, mid-October and early-February bull gaps sent shares soaring but were undone by the last six months of lower lows. For the past month though, the stock has found support at the $260 level. And while the shares are up 7.7% for the month so far, today's breakout has been stymied by their 40-day moving average.

The options pits show a preference for puts. BIIB sports a 10-day put/call volume ratio at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which ranks in the 74th percentile of readings from the past 12 months. Echoing this, Biogen stock's Schaeffer's put/call open interest ratio (SOIR) of 1.47 sits higher than 99% of readings in its annual range, suggesting short-term option players have rarely been more put-biased during the past 12 months.

Today though, options traders are targeting calls. In just the first hour of trading, over 4,500 calls have changed hands -- seven times the average intraday amount and volume pacing for the 99th percentile of its annual range. The most popular so far is the July 300 call, while new positions are being opened at the weekly 7/10 300-strike call.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?